Ultralife Corp (NASDAQ: ULBI)’s stock price has gone rise by 5.10 in comparison to its previous close of 7.45, however, the company has experienced a -0.25% decrease in its stock price over the last five trading days. seekingalpha.com reported 2025-05-09 that Ultralife Corporation (NASDAQ:ULBI ) Q1 2025 Earnings Conference Call May 9, 2025 10:00 AM ET Company Participants Alex Villalta – Investor Relations Mike Manna – President & Chief Executive Officer Phil Fain – Chief Financial Officer Conference Call Participants Josh Sullivan – The Benchmark Company Justin Mechetti – Sidoti & Company Operator Good day and thank you for standing by. Welcome to the Ultralife Corporation First Quarter 2025 Results.
Is It Worth Investing in Ultralife Corp (NASDAQ: ULBI) Right Now?
The price-to-earnings ratio for Ultralife Corp (NASDAQ: ULBI) is above average at 24.85x, Company’s 36-month beta value is 0.92.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ULBI is 10.07M, and currently, short sellers hold a 3.80% ratio of that floaft. The average trading volume of ULBI on June 13, 2025 was 79.13K shares.
ULBI’s Market Performance
The stock of Ultralife Corp (ULBI) has seen a -0.25% decrease in the past week, with a 41.85% rise in the past month, and a 46.63% gain in the past quarter. The volatility ratio for the week is 4.20%, and the volatility levels for the past 30 days are at 4.68% for ULBI. The simple moving average for the past 20 days is 17.38% for ULBI’s stock, with a 7.87% simple moving average for the past 200 days.
Analysts’ Opinion of ULBI
Many brokerage firms have already submitted their reports for ULBI stocks, with The Benchmark Company repeating the rating for ULBI by listing it as a “Buy.” The predicted price for ULBI in the upcoming period, according to The Benchmark Company is $12 based on the research report published on March 26, 2021 of the previous year 2021.
Ardour Capital gave a rating of “Hold” to ULBI, setting the target price at $4.50 in the report published on November 04th of the previous year.
ULBI Trading at 43.86% from the 50-Day Moving Average
After a stumble in the market that brought ULBI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -36.85% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ULBI starting from WHITMORE BRADFORD T, who purchase 11,980 shares at the price of $5.41 back on May 23 ’25. After this action, WHITMORE BRADFORD T now owns 1,060,067 shares of Ultralife Corp, valued at $64,778 using the latest closing price.
WHITMORE BRADFORD T, the Director of Ultralife Corp, purchase 16,063 shares at $5.47 during a trade that took place back on May 14 ’25, which means that WHITMORE BRADFORD T is holding 1,045,947 shares at $87,889 based on the most recent closing price.
Stock Fundamentals for ULBI
Current profitability levels for the company are sitting at:
- 0.05 for the present operating margin
- 0.25 for the gross margin
The net margin for Ultralife Corp stands at 0.03. The total capital return value is set at 0.05. Equity return is now at value 3.99, with 2.61 for asset returns.
Based on Ultralife Corp (ULBI), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at 6.49. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is 3.79.
Currently, EBITDA for the company is 14.4 million with net debt to EBITDA at -0.46. When we switch over and look at the enterprise to sales, we see a ratio of 0.72. The receivables turnover for the company is 4.81for trailing twelve months and the total asset turnover is 0.77. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.22.
Conclusion
In a nutshell, Ultralife Corp (ULBI) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
